Anteilseigner
Henlius Biopharmaceuticals, Inc. / Ky/ (26,77 %) Fosun International (21,74 %) Shanghai Fosun Pharm (18,98 %) Qatar Holding LLC (6,96 %) Qatar Investment Authority (Investment Management) (1,03 %) SSgA Funds Management, Inc. (0,09 %) China Universal Asset Management Co., Ltd. (0,08 %) Dimensional Fund Advisors LP (0,08 %) ICBC Credit Suisse Asset Management Co., Ltd. (0,06 %) DFA Australia Ltd. (0,01 %) Mackenzie Investments Corp. (United States) (0,00 %) Mackenzie Financial Corp. (0,00 %)
Kontakt
Shanghai Henlius Biotech Inc.